Skip to content

POZEN INC /NC

Delisted

CIK 1059790fmd_1BQ4X83BJ28JSQ1K30QT6SB0BXManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2015, 23 periods

Latest annual · FY2014

Millions
Total revenues
10
Net income
20

Latest quarter · Q4 FY2015

Millions
Net income
(8)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2011 to FY2014
-46.8%
Net income, 5 yearsFY2010 to FY2015
n/m

POZEN INC /NC financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2015FY2014ChangeSource
Net income$19.7 million-$16.7 million10-K 2015-03-11 · proof
Cash from operating activities$365,626-$878,94710-K 2015-03-11 · proof
Total assets$43.2 million$45.1 million-4%10-Q 2015-11-09 · proof
Total liabilities$14.2 million$7.3 million+95.3%10-Q 2015-11-09 · proof
Cash and cash equivalents$37 million$35.9 million+2.9%10-Q 2015-11-09 · proof
What was POZEN INC /NC's net income in fiscal 2015?
POZEN INC /NC reported net income of $19.7 million for fiscal 2015 (the year ended Dec 31, 2014), against -$16.7 million the year before. Source: the 10-K filed with the SEC on Mar 11, 2015. SEC
What was POZEN INC /NC's cash from operating activities in fiscal 2015?
POZEN INC /NC reported cash from operating activities of $365,626 for fiscal 2015 (the year ended Dec 31, 2014), against -$878,947 the year before. Source: the 10-K filed with the SEC on Mar 11, 2015. SEC
What are POZEN INC /NC's total assets?
As of Sep 30, 2015, POZEN INC /NC reported total assets of $43.2 million, against $45.1 million a year earlier (-4%). Source: the 10-Q filed with the SEC on Nov 9, 2015. SEC
What are POZEN INC /NC's total liabilities?
As of Sep 30, 2015, POZEN INC /NC reported total liabilities of $14.2 million, against $7.3 million a year earlier (+95.3%). Source: the 10-Q filed with the SEC on Nov 9, 2015. SEC
What are POZEN INC /NC's cash and cash equivalents?
As of Sep 30, 2015, POZEN INC /NC reported cash and cash equivalents of $37 million, against $35.9 million a year earlier (+2.9%). Source: the 10-Q filed with the SEC on Nov 9, 2015. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1059790&period_type=annual&limit=5"

Information only, not investment advice.